0001127602-21-010492.txt : 20210312
0001127602-21-010492.hdr.sgml : 20210312
20210312215953
ACCESSION NUMBER: 0001127602-21-010492
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210310
FILED AS OF DATE: 20210312
DATE AS OF CHANGE: 20210312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Day Daniel Patrick
CENTRAL INDEX KEY: 0001638643
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19731
FILM NUMBER: 21739640
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DRIVE
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES INC
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943047598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-03-10
0000882095
GILEAD SCIENCES INC
GILD
0001638643
O'Day Daniel Patrick
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
1
1
Chairman & CEO
Common Stock
2021-03-10
4
M
0
10800
A
147136
D
Common Stock
2021-03-10
4
F
0
5123
63.91
D
142013
D
Restricted Stock Unit
2021-03-10
4
A
0
52810
A
Common Stock
52810
161656
D
Non-qualified Stock Option (Right to Buy)
63.91
2021-03-10
4
A
0
307355
63.91
A
2021-03-12
Common Stock
307355
307355
D
Restricted Stock Unit
2021-03-10
4
M
0
10800
D
Common Stock
10800
150856
D
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
The options have a four-year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
/s/ Amy Kim by Power of Attorney for Daniel O'Day
2021-03-12